LEADER 01718nam  2200433   450 
001 9910707477803321
005 20160812155130.0
035   $a(CKB)5470000002464748
035   $a(OCoLC)951977301
035   $a(OCoLC)995470000002464748
035   $a(EXLCZ)995470000002464748
100   $a20160621d2008      ua             0
101 0 $aeng
135   $aurmn|||||||||
181   $2rdacontent
182   $2rdamedia
183   $2rdacarrier
200 10$aComparing special needs plan beneficiaries to other Medicare advantage prescription drug plan beneficiaries
210  1$a[Washington, D.C.] :$cDepartment of Health and Human Services, Office of Inspector General,$d2008.
215   $a1 online resource (iii, 36 pages) $cillustrations
300   $aTitle from title screen (viewed June 17, 2016).
300   $a"December 2008."
300   $a"OEI-05-07-00490."
320   $aIncludes bibliographical references.
517 1 $aComparing special needs plan beneficiaries to other Medicare advantage prescription drug plan beneficiaries
606   $aMedicare beneficiaries
606   $aPeople with disabilities$xMedical care$zUnited States
606   $aPharmaceutical services insurance$zUnited States$xEvaluation
606   $aPharmaceutical policy$zUnited States
615  0$aMedicare beneficiaries.
615  0$aPeople with disabilities$xMedical care
615  0$aPharmaceutical services insurance$xEvaluation.
615  0$aPharmaceutical policy
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910707477803321
996   $aComparing special needs plan beneficiaries to other Medicare advantage prescription drug plan beneficiaries$93312094
997   $aUNINA